Thomas P. Farrell
Thomas P. Farrell is Global Director, Immediate Release Technologies, at Colorcon Inc. (PA, USA).
Articles
Narrowing the gap between clinical capsule formulations and commercial film-coated tablets
May 1st 2009Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 23rd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 23rd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 23rd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 23rd 2024
Exploring Opportunities for LNP Delivery in mRNA
